Scopolamine and Cellulitis aggravated - a phase IV clinical study of FDA data

Summary:

Cellulitis aggravated is reported as a side effect among people who take Scopolamine (scopolamine), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Vancomycin, and have Nausea.

The phase IV clinical study analyzes which people have Cellulitis aggravated when taking Scopolamine. It is created by eHealthMe based on reports of 4,933 people who have side effects when taking Scopolamine from the FDA, and is updated regularly.

What is Scopolamine?

Scopolamine has active ingredients of scopolamine. eHealthMe is studying from 4,945 Scopolamine users. Check the latest studies of Scopolamine.

What is Cellulitis aggravated?

Cellulitis aggravated (worst condition of inaction under skin) is found to be associated with 1,545 drugs and 619 conditions by eHealthMe. Check the latest studies of Cellulitis aggravated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 29, 2026

4,933 people reported to have side effects when taking Scopolamine.
Among them, 69 people (1.4%) have Cellulitis aggravated.

Could Scopolamine cause Cellulitis aggravated?

Among these 69 people:

How long have people been on Scopolamine when they have Cellulitis aggravated? *

What is the gender of people who have Cellulitis aggravated when taking Scopolamine? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Cellulitis aggravated when taking Scopolamine? *

What are other drugs people take besides Scopolamine? *

What are other side effects people have besides Cellulitis aggravated? *

Fever: 34 people, 49.28%
Pain: 33 people, 47.83%
Chest Pain: 28 people, 40.58%
Nausea (feeling of having an urge to vomit): 28 people, 40.58%
Neuropathy Peripheral (surface nerve damage): 27 people, 39.13%
Bone Disorder: 27 people, 39.13%
Weakness: 27 people, 39.13%
Stress And Anxiety: 27 people, 39.13%
Fatigue (feeling of tiredness): 26 people, 37.68%
Arrhythmias (irregular heartbeat): 26 people, 37.68%

What are the existing conditions these people have? *

Nausea (feeling of having an urge to vomit): 11 people, 15.94%
Constipation: 10 people, 14.49%
Neoplasm Malignant (cancer tumour): 10 people, 14.49%
Pain: 10 people, 14.49%
Breast Cancer: 10 people, 14.49%
Immunodeficiency Common Variable: 9 people, 13.04%
Indigestion: 8 people, 11.59%
Infection: 8 people, 11.59%
Tumor Lysis Syndrome: 8 people, 11.59%
Hypersensitivity: 8 people, 11.59%

* Approximation only. Some reports may have incomplete information.

Do you take Scopolamine and have Cellulitis aggravated?

- Check whether Cellulitis aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Scopolamine:

Scopolamine (4,945 reports)

Browse all side effects of Scopolamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cellulitis aggravated:

Cellulitis aggravated (1,545 drugs)

Browse all the conditions that are associated with Cellulitis aggravated:

Cellulitis aggravated (619 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on scopolamine (the active ingredients of Scopolamine) and Scopolamine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.